Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

FDA Reclassification of Hepatitis B Virus (HBV) Assay Devices: Compliance and Implementation Training

$129.99

Stay ahead in the diagnostics industry with this targeted course on the FDA’s final order reclassifying qualitative HBV antigen assays, HBV antibody assays, and quantitative HBV nucleic acid-based assays from Class III to Class II, subject to special controls and premarket notification. Learn the actionable compliance steps, understand the new regulatory requirements, and avoid costly enforcement actions. This training is essential for manufacturers, regulatory professionals, and laboratories bringing HBV diagnostic devices to market.

In this course you will learn the following:
* Understand the regulatory background and rationale for the reclassification.
* Identify the new classification and special controls for each HBV assay device type.
* Implement the required steps for compliance, including premarket notification and adherence to special controls.
* Recognize the legal and financial consequences of failing to comply with the final rule.
* Prepare for the effective date and ongoing compliance requirements.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Why This Course is Important
Without this course, manufacturers and professionals risk missing critical deadlines, failing to implement required special controls, and incurring costly regulatory penalties that can disrupt product launches or ongoing market access for HBV diagnostic devices.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices.

Key regulatory references include:

Course SKU
FR-25-1533-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

FDA Reclassification of Hepatitis B Virus (HBV) Assay Devices: Compliance and Implementation Training

Stay ahead in the diagnostics industry with this targeted course on the FDA’s final order reclassifying qualitative HBV antigen assays, HBV antibody assays, and quantitative HBV nucleic acid-based assays from Class III to Class II, subject to special controls and premarket notification. Learn the actionable compliance steps, understand the new regulatory requirements, and avoid costly enforcement actions. This training is essential for manufacturers, regulatory professionals, and laboratories bringing HBV diagnostic devices to market.

In this course you will learn the following:
* Understand the regulatory background and rationale for the reclassification.
* Identify the new classification and special controls for each HBV assay device type.
* Implement the required steps for compliance, including premarket notification and adherence to special controls.
* Recognize the legal and financial consequences of failing to comply with the final rule.
* Prepare for the effective date and ongoing compliance requirements.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Why This Course is Important
Without this course, manufacturers and professionals risk missing critical deadlines, failing to implement required special controls, and incurring costly regulatory penalties that can disrupt product launches or ongoing market access for HBV diagnostic devices.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices.

Key regulatory references include:

Course SKU
FR-25-1533-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

FDA Reclassification of Hepatitis B Virus (HBV) Assay Devices: Compliance and Implementation Training

$129.99

Why This Course is Important
Without this course, manufacturers and professionals risk missing critical deadlines, failing to implement required special controls, and incurring costly regulatory penalties that can disrupt product launches or ongoing market access for HBV diagnostic devices.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices.

Key regulatory references include:

Course SKU
FR-25-1533-1

Stay ahead in the diagnostics industry with this targeted course on the FDA’s final order reclassifying qualitative HBV antigen assays, HBV antibody assays, and quantitative HBV nucleic acid-based assays from Class III to Class II, subject to special controls and premarket notification. Learn the actionable compliance steps, understand the new regulatory requirements, and avoid costly enforcement actions. This training is essential for manufacturers, regulatory professionals, and laboratories bringing HBV diagnostic devices to market.

In this course you will learn the following:
* Understand the regulatory background and rationale for the reclassification.
* Identify the new classification and special controls for each HBV assay device type.
* Implement the required steps for compliance, including premarket notification and adherence to special controls.
* Recognize the legal and financial consequences of failing to comply with the final rule.
* Prepare for the effective date and ongoing compliance requirements.

Related products